DKK1 levels, however, were substantially reduced in several cancers, including prostate adenocarcinoma (PRAD), kidney renal papillary cell carcinoma (KIRP), breast invasive carcinoma (BRCA), kidney chromophobe (KICH), and bladder urothelial carcinoma (BLCA). Here, DKK1 is linked to cancer.